Find more facts and information on our topic page about
Rigel
supergiant
supergiant The largest and brightest type of star, with a luminosity of about 10 000–100 000 times the Sun's, and a diameter from 20 to several hundred times the Sun's. Stars of at least 10 solar masses become supergiants when they swell up and leave the main sequence towards the end of their lives. They occupy a band at the top of the Hertzsprung–Russell diagram and are of
luminosity class I. Rigel and Betelgeuse are well-known supergiants.
Cite this article
Pick a style below, and copy the text for your bibliography.
|
Rigel Pharmaceuticals' Stockholders Approve Financing and Other Related Proposals at Annual Stockholders' Meeting.
PR Newswire; 6/21/2003; 700+ words
; Rigel Pharmaceuticals, Inc. announced today that it received...submitted for stockholder vote and identified in Rigel's 2003 proxy statement. Among the proposals receiving approval were Rigel's recently announced financing, a reverse stock...
|
|
|
Rigel Announces Third Quarter 2008 Financial Results and Clinical Update.
PR Newswire; 11/3/2008; 700+ words
; ...Nov. 3 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. today reported...2008. For the third quarter of 2008, Rigel reported a net loss of $37.7 million...in the third quarters of 2008 and 2007. Rigel reported operating expenses of $38.7...
|
|
|
Rigel Ubiquitin Ligase Program Identifies Molecules With Anti-HIV Activity.
PR Newswire; 3/27/2007; 700+ words
; Rigel Program to be Presented at Keystone Scientific...March 27 /PRNewswire-FirstCall/ -- Rigel today announced that Yonchu Jenkins, Ph...Function. Dr. Jenkins and her colleagues at Rigel are investigating ways to inhibit Vif, a...
|
|
|
Rigel Announces 2002 Fiscal Year Financial Results; Company Provides Outlook for 2003 Clinical Progress.
PR Newswire; 2/5/2003; 700+ words
; ...Calif., Feb. 5 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. today reported...with the start of clinical testing for Rigel's first product candidate. Net loss...fiscal 2001. As of December 31, 2002, Rigel had cash, cash equivalents and short...
|
|
|
Rigel Granted Key Patents in Immunology, Virology and Oncology.
PR Newswire; 3/21/2006; 700+ words
; ...March 21 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. today announced...patents since February 2004. Specifically, Rigel was granted six patents in immunology...Activated Cell Sorter (FACS) technology. Rigel is ranked as one of the top 15 biotech...
|
|
|
Rigel Announces Restructuring To Reduce Spending; Company Cuts Staff While Increasing Focus on Major Drug Development Programs.
PR Newswire; 2/1/2003; 700+ words
; Rigel Pharmaceuticals announced today that the...As a result of this reduction in force, Rigel will realign its personnel base, predominantly...company's drug development capabilities. Rigel also announced today that, separately from...
|
|
|
Rigel Pharmaceuticals Presents Drug Development Programs in Oncology and Allergy/Inflammation at the Protein Phosphorylation Drug Discovery World Summit; Presentations to Feature Latest Results on Inhibitors of Ubiquitin Ligases and Selected Kinases as Potential Drug Candidates.
PR Newswire; 3/5/2003; 700+ words
; Rigel Pharmaceuticals, Inc., announced today...for the treatment of cancer. Another of Rigel's programs focuses on a kinase drug target...arthritis," said Donald G. Payan, M.D., Rigel's executive vice president and chief scientific...
|
|
|
Rigel Announces Fourth Quarter and Year End 2007 Financial Results.
PR Newswire; 2/12/2008; 700+ words
; ...Feb. 12 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. today announced...2007. For the fourth quarter of 2007, Rigel reported a net loss of $19.0 million...million and 25.1 million, respectively. Rigel reported revenue from collaborations of...
|
|
|
Rigel to Host Conference Call to Discuss Phase 2 Study Results of R788 in ITP.
PR Newswire; 11/21/2007; 700+ words
; ...Nov. 21 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. today announced...T. Participating on the call will be Rigel senior management and the principal investigator...Cornell Medical College. In addition, Rigel will be presenting a poster on R788 in...
|
|
|
Rigel Announces Issuance of HCV and Inflammation Patents; 20 Patents Issued in Last 18 Months.
PR Newswire; 1/6/2004; 700+ words
; Rigel Pharmaceuticals, Inc. today announced that it...19 other U.S. patents that have been issued to Rigel during the last 18 months. These patents cover core technology useful in Rigel's HCV program, as well as its immunology and...
|
|
Rigel
Book article from: The Columbia Encyclopedia, Sixth Edition
Rigel , bright star in the constellation Orion...blue supergiant of spectral class B8 Ia, Rigel has an intrinsic brightness about 40,000...the earth is nearly 1,000 light-years. Rigel is actually a four-star system consisting...
|
|
Geographic Profiling
Book article from: World of Forensic Science
...software used for geographic profiling — Rigel Profiler and Rigel Analyst (both created by Rossmo's Vancouver-based...investigations in order to locate the serial offender. From the Rigel software, this map can be a two-dimensional or three...
|
|
|
red giant
Book article from: The Columbia Encyclopedia, Sixth Edition
...yellow). The largest and brightest stars (excluding supernovas ) are classed as supergiants. Blue supergiants, e.g., Rigel , are young stars on the main sequence of the Hertzsprung-Russell diagram , whereas red supergiants, e.g., Betelgeuse...
|
|
Orion
Book article from: A Dictionary of Astronomy
...equator, representing a great hunter of Greek mythology. Orion is outlined by the prominent stars Betelgeuse (Alpha Orionis), Rigel (Beta Orionis, the constellation's brightest star), Bellatrix (Gamma Orionis), and Saiph (Kappa Orionis). A line...
|
|
|
brightest stars, The
Book article from: A Dictionary of Astronomy
...Capella α Aurigae 05 16.7 +46 00 0.08 b G8III + G0III 42.2 −0.48 Rigel β Orionis 05 14.5 −08 12 0.18 b B8Iab 773 −6.69 Procyon...
|
